Galderma’s Liquid Botox: Redefining Aesthetic Medicine Beauty Trends
Galderma's Phase III studies show promising results for their liquid botulinum toxin A, RelabotulinumtoxinA, in reducing frown and crow’s feet lines. The innovative treatment signifies progress in aesthetic medicine, offering enhanced precision and potentially setting new standards.